Patent · US Active

Lipid nanoparticles for delivering mRNA vaccines

US11771653B2 · kind B2 · utility

2Cited by

57References

53Claims

0Family size

Assignee

Sanofi · FR

Inventors

Danilo Casimiro · Harleysville, US
Sudha CHIVUKULA · Paris, FR
Kirill Kalnin · Pelham, US
Timothy PLITNIK · Paris, FR
Timothy TIBBITTS · Paris, FR
Frank DeRosa · Lexington, US
Anusha Dias · Cambridge, US
Rebecca L. Goldman · Paris, FR
Hardip Rajeshbhai GOPANI · Paris, FR
Shrirang Karve · Lexington, US
Asad KHANMOHAMMED · Paris, FR
Priyal Patel · Lexington, US

Key dates

Filing date	Jun 30, 2022
Grant date	Oct 3, 2023
Priority date	—
Expiry date	Jun 30, 2042

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2039/55555
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided are novel lipid nanoparticles for delivering nucleic acids such as mRNA. Also provided are methods of making and using lipid nanoparticles for delivering nucleic acids such as mRNA.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.